- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.11. | Lilly and MeiraGTx partner in $475m ophthalmology deal | ||
| 13.11. | Smurfit Westrock unveils new clinical packaging facility at Dublin Airport | ||
| 12.11. | Johnson & Jonson secures FDA approval for multiple myeloma treatment | ||
| 12.11. | AstraZeneca reports positive results from phase 3 blood pressure trial | ||
| 12.11. | GenAI tools - creating a new era of scientific research | ||
| 11.11. | Genentech announces positive clinical results for BTK inhibitor MS treatment | ||
| 11.11. | Merck and Blackstone agree on funding for cancer protein antibody | ||
| 11.11. | The hidden strength of teams: how collaboration can build resilience | ||
| 10.11. | LEO Pharma receives NICE approval for chronic hand eczema cream | ||
| 10.11. | Pfizer and Metsera agree on merger after bidding war between Pfizer and Novo Nordisk | ||
| 10.11. | From disruption to resilience: India's growing role in pharma logistics | ||
| 07.11. | Novo Nordisk agrees to lower certain drug prices in the US | ||
| 07.11. | Lilly announces agreement with US government to lower patient costs | ||
| 07.11. | Support your backbone with legacy brands that deliver competitive edge | ||
| 06.11. | Boehringer Ingelheim and CDR-Life agree on deal worth up to $570m | ||
| 06.11. | Electra Therapeutics secures regulatory designations and funding for lead sHLH candidate | ||
| 06.11. | A new advent of clinical pathway management | ||
| 05.11. | Sandoz to acquire Just-Evotec Biologics to strengthen biosimilar development and manufacturing capabilities | ||
| 05.11. | Novo Nordisk reports sales growth in 2025 as R&D pipeline advances | ||
| 05.11. | Resilience - the importance of maintaining our well-being | ||
| 04.11. | Lilly announces plan for new $3bn facility to boost manufacturing in Europe | ||
| 04.11. | Uniphar strengthens US leadership team amid expansion | ||
| 04.11. | Physician-driven, AI-supported: addressing the clinical trial access gap | ||
| 03.11. | Novartis reports positive phase 3 results for Cosentyx in polymyalgia rheumatica | ||
| 03.11. | Uniphar announces US expansion and company integration |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .